{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T08:54:07Z","timestamp":1770972847475,"version":"3.50.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2008,3,25]],"date-time":"2008-03-25T00:00:00Z","timestamp":1206403200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Gastroenterol Hepatol"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1038\/ncpgasthep1099","type":"journal-article","created":{"date-parts":[[2008,3,25]],"date-time":"2008-03-25T16:26:49Z","timestamp":1206462409000},"page":"278-281","source":"Crossref","is-referenced-by-count":9,"title":["A case of fistulizing Crohn's disease and erythema nodosum managed with adalimumab"],"prefix":"10.1038","volume":"5","author":[{"given":"Alissa","family":"Quin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunanda","family":"Kane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga","family":"Ulitsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,3,25]]},"reference":[{"key":"BFncpgasthep1099_CR1","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.sder.2007.02.009","volume":"26","author":"L Requena","year":"2007","unstructured":"Requena L and S\u00e1nchez YE (2007) Erythema nodosum. Semin Cutan Med Surg 26: 114\u2013125","journal-title":"Semin Cutan Med Surg"},{"key":"BFncpgasthep1099_CR2","first-page":"695","volume":"75","author":"R Schwartz","year":"2007","unstructured":"Schwartz R and Nervi S (2007) Erythema nodosum: a sign of systemic disease. Am Fam Physician 75: 695\u2013700","journal-title":"Am Fam Physician"},{"key":"BFncpgasthep1099_CR3","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1136\/pgmj.2004.031633","volume":"81","author":"L Trost","year":"2005","unstructured":"Trost L and McDonnell JK (2005) Important cutaneous manifestation of inflammatory bowel disease. Postgrad Med J 81: 580\u2013585","journal-title":"Postgrad Med J"},{"key":"BFncpgasthep1099_CR4","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1503\/cmaj.050201","volume":"173","author":"M Weinstein","year":"2005","unstructured":"Weinstein M  et al. (2005) Erythema nodosum as a presentation of inflammatory bowel disease. Can Med Assoc J 173: 145\u2013146","journal-title":"Can Med Assoc J"},{"issue":"Suppl 4","key":"BFncpgasthep1099_CR5","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/j.1365-2036.2004.02055.x","volume":"20","author":"F Tavarela Veloso","year":"2004","unstructured":"Tavarela Veloso F (2004) Review article: skin complications associated with inflammatory bowel disease. Aliment Pharmacol Ther 20 (Suppl 4): 50\u201353","journal-title":"Aliment Pharmacol Ther"},{"key":"BFncpgasthep1099_CR6","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1097\/00004836-200607000-00003","volume":"40","author":"SR Kethu","year":"2006","unstructured":"Kethu SR (2006) Extraintestinal manifestations of inflammatory bowel diseases. J Clin Gastroenterol 40: 467\u2013475","journal-title":"J Clin Gastroenterol"},{"key":"BFncpgasthep1099_CR7","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1111\/j.1572-0241.2006.00504.x","volume":"101","author":"GC Nguyen","year":"2006","unstructured":"Nguyen GC (2006) Inflammatory bowel disease characteristics among African Americans, Hispanics, and non-Hispanic Whites: characterization of a large North American cohort. Am J Gastroenterol 101: 1012\u20131023","journal-title":"Am J Gastroenterol"},{"key":"BFncpgasthep1099_CR8","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.gtc.2006.09.001","volume":"35","author":"A Barrie","year":"2006","unstructured":"Barrie A and Plevy S (2006) Treatment of immune-mediated extraintestinal manifestations of inflammatory bowel disease with infliximab. Gastroenterol Clin North Am 35: 883\u2013893","journal-title":"Gastroenterol Clin North Am"},{"key":"BFncpgasthep1099_CR9","doi-asserted-by":"publisher","first-page":"e55","DOI":"10.1016\/j.jaad.2006.07.019","volume":"56","author":"JE Graves","year":"2007","unstructured":"Graves JE  et al. (2007) Off-label uses of biologics in dermatology: rituximab, omalizumab, infliximab, etanercept, adalimumab, efalizumab, and alefacept (part 2 of 2). J Am Acad Dermatol 56: e55\u201379","journal-title":"J Am Acad Dermatol"},{"key":"BFncpgasthep1099_CR10","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1111\/j.1572-0241.2005.40647.x","volume":"100","author":"KA Papadakis","year":"2005","unstructured":"Papadakis KA  et al. (2005) Safety and efficacy of adalimumab (D2E7) in Crohn's disease patients with an attenuated response to infliximab. Am J Gastroenterol 100: 75\u201379","journal-title":"Am J Gastroenterol"},{"key":"BFncpgasthep1099_CR11","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1111\/j.1572-0241.2004.40462.x","volume":"99","author":"W Sandborn","year":"2004","unstructured":"Sandborn W  et al. (2004) An open-label study of the human anti-TNF monoclonal antibody adalimumab in subjects with prior loss of response or intolerance to infliximab for Crohn's disease. Am J Gastroenterol 99: 1984\u20131989","journal-title":"Am J Gastroenterol"},{"key":"BFncpgasthep1099_CR12","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1053\/j.gastro.2005.11.030","volume":"130","author":"SB Hanauer","year":"2006","unstructured":"Hanauer SB  et al. (2006) Human anti-tumor necrosis factor monoclonal antibody (Adalimumab) in Crohn's disease: the CLASSIC-I Trial. Gastroenterology 130: 323\u2013333","journal-title":"Gastroenterology"},{"key":"BFncpgasthep1099_CR13","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1136\/gut.2005.065417","volume":"54","author":"L Vesga","year":"2005","unstructured":"Vesga L  et al. (2005) Adalimumab use in pregnancy. Gut 54: 890","journal-title":"Gut"},{"key":"BFncpgasthep1099_CR14","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1111\/j.1468-3083.2006.01893.x","volume":"21","author":"N Ortego-Centeno","year":"2007","unstructured":"Ortego-Centeno N  et al. (2007) Refractory chronic erythema nodosum successfully treated with adalimumab. J Eur Acad Dermatol Venereol 21: 409\u2013410","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"BFncpgasthep1099_CR15","first-page":"e8","volume":"5","author":"MA Fonder","year":"2006","unstructured":"Fonder MA  et al. (2006) Adalimumab therapy for recalcitrant pyoderma gangrenosum. J Burns Wounds 5: e8","journal-title":"J Burns Wounds"}],"container-title":["Nature Clinical Practice Gastroenterology & Hepatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ncpgasthep1099.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncpgasthep1099","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncpgasthep1099.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T20:08:03Z","timestamp":1684440483000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncpgasthep1099"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3,25]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["BFncpgasthep1099"],"URL":"https:\/\/doi.org\/10.1038\/ncpgasthep1099","relation":{},"ISSN":["1743-4378","1743-4386"],"issn-type":[{"value":"1743-4378","type":"print"},{"value":"1743-4386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,3,25]]}}}